𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Sirolimus- versus paclitaxel-eluting stents for unselected patients with coronary artery disease

✍ Scribed by Seung-Jung Park,

Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
38 KB
Volume
77
Category
Article
ISSN
1522-1946

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Selective versus exclusive use of siroli
Selective versus exclusive use of sirolimus-eluting stent implantation in multivessel coronary artery disease
✍ William W. Chu; Seung-Woon Rha; Pramod K. Kuchulakanti; Edouard Cheneau; Rebecca πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 52 KB πŸ‘ 2 views

Sirolimus-eluting stents (SESs; Cypher) have demonstrated a significant reduction in restenosis rates when compared to bare metal stents (BMSs). The purpose of this study was to evaluate the strategy of exclusive use of two SESs versus the combination of one BMS and one SES for two-vessel coronary a

Impact of three or more sirolimus-elutin
Impact of three or more sirolimus-eluting stents versus paclitaxel-eluting stents on clinical outcomes in patients undergoing percutaneous coronary intervention
✍ William W. Chu; Pramod K. Kuchulakanti; Rebecca Torguson; Betty Wang; Leonardo C πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 75 KB πŸ‘ 2 views

## Abstract ## Objectives: The purpose of this study was to examine the clinical outcomes of patients who underwent stenting with β‰₯3 sirolimus‐eluting stents (SES) when compared with those treated with β‰₯3 paclitaxel‐eluting stents (PES). ## Background: Drug‐eluting stent (DES) implantation for s